Page last updated: 2024-08-17

adenosine monophosphate and thromboxane a2

adenosine monophosphate has been researched along with thromboxane a2 in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Humphries, RG; Jarvis, GE; Leff, P; Robertson, MJ1
Cameron, KE; Heptinstall, S; May, JA; Sanderson, HM; Storey, RF; White, AE1
Bryckaert, M; Habib, A; Jandrot-Perrus, M; Pawlowski, M; Roger, S; Rosa, JP1
Garcia, A; Kim, S; Kunapuli, SP; Prabhakar, J; Shankar, H1
Dawood, BB; Watson, SP; Wilde, J1

Trials

1 trial(s) available for adenosine monophosphate and thromboxane a2

ArticleYear
Reference curves for aggregation and ATP secretion to aid diagnose of platelet-based bleeding disorders: effect of inhibition of ADP and thromboxane A(2) pathways.
    Platelets, 2007, Volume: 18, Issue:5

    Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Blood Platelets; Cyclooxygenase Inhibitors; Diagnosis, Differential; Female; Hemorrhage; Humans; Indomethacin; Male; Platelet Aggregation; Platelet Function Tests; Purinergic P2 Receptor Agonists; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2; Receptors, Purinergic P2Y1; Receptors, Purinergic P2Y12; Reference Standards; Secretory Vesicles; Thromboxane A2

2007

Other Studies

4 other study(ies) available for adenosine monophosphate and thromboxane a2

ArticleYear
ADP can induce aggregation of human platelets via both P2Y(1) and P(2T) receptors.
    British journal of pharmacology, 2000, Volume: 129, Issue:2

    Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adult; Algorithms; Binding, Competitive; Female; Humans; In Vitro Techniques; Male; Membrane Proteins; Platelet Aggregation; Platelet Aggregation Inhibitors; Receptors, Purinergic P2; Receptors, Purinergic P2Y1; Receptors, Purinergic P2Y12; Thromboxane A2

2000
The central role of the P(2T) receptor in amplification of human platelet activation, aggregation, secretion and procoagulant activity.
    British journal of haematology, 2000, Volume: 110, Issue:4

    Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine Diphosphate; Adenosine Monophosphate; Analysis of Variance; Annexin A5; Aspirin; Blood Platelets; Calcium; Collagen; Cytosol; Fibrinolytic Agents; Flow Cytometry; Humans; Membrane Proteins; P-Selectin; Peptide Fragments; Platelet Activation; Platelet Aggregation; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2; Receptors, Purinergic P2X; Receptors, Purinergic P2Y1; Receptors, Purinergic P2Y12; Serotonin; Stimulation, Chemical; Thromboxane A2

2000
Costimulation of the Gi-coupled ADP receptor and the Gq-coupled TXA2 receptor is required for ERK2 activation in collagen-induced platelet aggregation.
    FEBS letters, 2004, Jan-02, Volume: 556, Issue:1-3

    Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine Diphosphate; Adenosine Monophosphate; Animals; Cattle; Collagen; Enzyme Activation; Epinephrine; GTP-Binding Protein alpha Subunits, Gi-Go; Humans; Integrin alpha2beta1; Membrane Proteins; Mitogen-Activated Protein Kinase 1; Phosphorylation; Platelet Aggregation; Platelet Membrane Glycoproteins; Protein Kinase C; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2; Receptors, Purinergic P2Y12; Receptors, Thromboxane A2, Prostaglandin H2; Signal Transduction; Thromboxane A2

2004
P2Y12 receptor-mediated potentiation of thrombin-induced thromboxane A2 generation in platelets occurs through regulation of Erk1/2 activation.
    Journal of thrombosis and haemostasis : JTH, 2006, Volume: 4, Issue:3

    Topics: Adenosine Monophosphate; Animals; Blood Platelets; Butadienes; Clopidogrel; Enzyme Inhibitors; Humans; Membrane Proteins; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinase Kinases; Models, Biological; Nitriles; Phospholipases A; Phospholipases A2; Platelet Aggregation Inhibitors; Pyrimidines; Receptor, PAR-1; Receptors, Purinergic P2; Receptors, Purinergic P2Y12; Receptors, Thrombin; Signal Transduction; src-Family Kinases; Thrombin; Thromboxane A2; Ticlopidine

2006